Use of HPMA copolymers in gene delivery

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Effective therapeutic application of gene drugs requires noninvasive and cost-effective methods for gene delivery, which should be safe for repetitive use and provide reproducible therapeutic effect. Systematic research efforts in the area of polyelectrolyte complexes of DNA with polycations (polyplexes) resulted in an increased understanding of the principles governing the biological activity of polyplexes and now permit rational design of increasingly more efficient vectors. Despite this tremendous progress, significant constrains limiting the efficiency of the gene delivery process mediated by polyplexes still remain, particularly when they are administered systemically.1 The growing emphasis on the systemic delivery of genes via intravenous injection reflects the need to gain access to disseminated and widespread disease targets, such as cancer cells, and to expand the available therapeutic modalities. To construct a delivery system suitable for systemic administration, a thorough understanding of the in vivo pharmacokinetic and disposition characteristics of the vector is important.2 The distribution and elimination patterns of systemically administered polyplexes largely follow general behavior observed for other macromolecules and nanoparticles, and depend mainly on the physicochemical properties of the carrier, such as size and molecular weight, electric charge, and hydrophilic/hydrophobic balance.3,4 Based on the accurate understanding of the relationship between the physicochemical properties of macromolecular carriers and their pharmacokinetics, it is often possible to effectively control their disposition properties.

Original languageEnglish (US)
Title of host publicationPolymeric Gene Delivery
Subtitle of host publicationPrinciples and Applications
PublisherCRC Press
Pages345-354
Number of pages10
ISBN (Electronic)9780203500477
ISBN (Print)9780849319341
DOIs
StatePublished - Jan 1 2004

Fingerprint

hydroxypropyl methacrylate
Copolymers
Genes
Pharmacokinetics
Electric charge
Therapeutic Uses
Bioactivity
Polyelectrolytes
Macromolecules
Intravenous Injections
Nanoparticles
Molecular Weight
Molecular weight
Cells
Costs and Cost Analysis
DNA
Therapeutics
Research

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Oupicky, D. (2004). Use of HPMA copolymers in gene delivery. In Polymeric Gene Delivery: Principles and Applications (pp. 345-354). CRC Press. https://doi.org/10.1201/9780203500477

Use of HPMA copolymers in gene delivery. / Oupicky, David.

Polymeric Gene Delivery: Principles and Applications. CRC Press, 2004. p. 345-354.

Research output: Chapter in Book/Report/Conference proceedingChapter

Oupicky, D 2004, Use of HPMA copolymers in gene delivery. in Polymeric Gene Delivery: Principles and Applications. CRC Press, pp. 345-354. https://doi.org/10.1201/9780203500477
Oupicky D. Use of HPMA copolymers in gene delivery. In Polymeric Gene Delivery: Principles and Applications. CRC Press. 2004. p. 345-354 https://doi.org/10.1201/9780203500477
Oupicky, David. / Use of HPMA copolymers in gene delivery. Polymeric Gene Delivery: Principles and Applications. CRC Press, 2004. pp. 345-354
@inbook{3fb20a6c7519460abc20526d86088e6d,
title = "Use of HPMA copolymers in gene delivery",
abstract = "Effective therapeutic application of gene drugs requires noninvasive and cost-effective methods for gene delivery, which should be safe for repetitive use and provide reproducible therapeutic effect. Systematic research efforts in the area of polyelectrolyte complexes of DNA with polycations (polyplexes) resulted in an increased understanding of the principles governing the biological activity of polyplexes and now permit rational design of increasingly more efficient vectors. Despite this tremendous progress, significant constrains limiting the efficiency of the gene delivery process mediated by polyplexes still remain, particularly when they are administered systemically.1 The growing emphasis on the systemic delivery of genes via intravenous injection reflects the need to gain access to disseminated and widespread disease targets, such as cancer cells, and to expand the available therapeutic modalities. To construct a delivery system suitable for systemic administration, a thorough understanding of the in vivo pharmacokinetic and disposition characteristics of the vector is important.2 The distribution and elimination patterns of systemically administered polyplexes largely follow general behavior observed for other macromolecules and nanoparticles, and depend mainly on the physicochemical properties of the carrier, such as size and molecular weight, electric charge, and hydrophilic/hydrophobic balance.3,4 Based on the accurate understanding of the relationship between the physicochemical properties of macromolecular carriers and their pharmacokinetics, it is often possible to effectively control their disposition properties.",
author = "David Oupicky",
year = "2004",
month = "1",
day = "1",
doi = "10.1201/9780203500477",
language = "English (US)",
isbn = "9780849319341",
pages = "345--354",
booktitle = "Polymeric Gene Delivery",
publisher = "CRC Press",

}

TY - CHAP

T1 - Use of HPMA copolymers in gene delivery

AU - Oupicky, David

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Effective therapeutic application of gene drugs requires noninvasive and cost-effective methods for gene delivery, which should be safe for repetitive use and provide reproducible therapeutic effect. Systematic research efforts in the area of polyelectrolyte complexes of DNA with polycations (polyplexes) resulted in an increased understanding of the principles governing the biological activity of polyplexes and now permit rational design of increasingly more efficient vectors. Despite this tremendous progress, significant constrains limiting the efficiency of the gene delivery process mediated by polyplexes still remain, particularly when they are administered systemically.1 The growing emphasis on the systemic delivery of genes via intravenous injection reflects the need to gain access to disseminated and widespread disease targets, such as cancer cells, and to expand the available therapeutic modalities. To construct a delivery system suitable for systemic administration, a thorough understanding of the in vivo pharmacokinetic and disposition characteristics of the vector is important.2 The distribution and elimination patterns of systemically administered polyplexes largely follow general behavior observed for other macromolecules and nanoparticles, and depend mainly on the physicochemical properties of the carrier, such as size and molecular weight, electric charge, and hydrophilic/hydrophobic balance.3,4 Based on the accurate understanding of the relationship between the physicochemical properties of macromolecular carriers and their pharmacokinetics, it is often possible to effectively control their disposition properties.

AB - Effective therapeutic application of gene drugs requires noninvasive and cost-effective methods for gene delivery, which should be safe for repetitive use and provide reproducible therapeutic effect. Systematic research efforts in the area of polyelectrolyte complexes of DNA with polycations (polyplexes) resulted in an increased understanding of the principles governing the biological activity of polyplexes and now permit rational design of increasingly more efficient vectors. Despite this tremendous progress, significant constrains limiting the efficiency of the gene delivery process mediated by polyplexes still remain, particularly when they are administered systemically.1 The growing emphasis on the systemic delivery of genes via intravenous injection reflects the need to gain access to disseminated and widespread disease targets, such as cancer cells, and to expand the available therapeutic modalities. To construct a delivery system suitable for systemic administration, a thorough understanding of the in vivo pharmacokinetic and disposition characteristics of the vector is important.2 The distribution and elimination patterns of systemically administered polyplexes largely follow general behavior observed for other macromolecules and nanoparticles, and depend mainly on the physicochemical properties of the carrier, such as size and molecular weight, electric charge, and hydrophilic/hydrophobic balance.3,4 Based on the accurate understanding of the relationship between the physicochemical properties of macromolecular carriers and their pharmacokinetics, it is often possible to effectively control their disposition properties.

UR - http://www.scopus.com/inward/record.url?scp=85055549406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055549406&partnerID=8YFLogxK

U2 - 10.1201/9780203500477

DO - 10.1201/9780203500477

M3 - Chapter

AN - SCOPUS:85055549406

SN - 9780849319341

SP - 345

EP - 354

BT - Polymeric Gene Delivery

PB - CRC Press

ER -